Champions Oncology, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Baltimore, MD
CSBR chart
What traders are saying about $CSBR
Latest postsChampions Oncology, Inc. news
- Champions Oncology, Inc. Estimates – NASDAQ:CSBR
TradingView ·
- Capitalize on the Global PDX Models Shift: Benchmark Charles River, Crown Bioscience, Champions Oncology, The Jackson Laboratory and Oncodesign to Secure Precision Oncology ROI
Yahoo Finance ·
- CSBR Stock Slips Post Q1 Earnings Despite Revenue, Margin Growth
Yahoo Finance ·
- Champions Oncology Inc (CSBR) (Q1 2027) Earnings Call Highlights: Data Licensing Surge and ...
Yahoo Finance ·
- Champions Oncology (CSBR) Q1 2027 Earnings Call Transcript
fool.com ·
- Champions Oncology, Inc. Q1 2027 Earnings Call Summary
app.moby.co ·
- Champions Oncology Q1 Earnings Call Highlights
marketbeat.com ·
- Champions Oncology Reports Revenue of $15.2 Million
Yahoo Finance ·
- Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2026
Yahoo Finance ·
- Champions Oncology Expands Integrated Radiopharmaceutical Development Platform with In-House SPECT/CT Imaging
Yahoo Finance ·
- Champions Oncology Inc (CSBR) (Q4 2026) Earnings Call Highlights: Record Revenue and Positive ...
Yahoo Finance ·
- Champions Oncology Q4 Earnings Call Highlights
marketbeat.com ·
Champions Oncology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $59.4M | $56.9M | $50.2M | $53.9M |
| Net income | -$1,175 | $4,701 | -$7,276 | -$5.3M |
| Diluted EPS | $-0.08 | $0.33 | $-0.54 | $-0.39 |
| Total assets (year end) | $28.4M | $30.6M | $26.8M | $36.2M |
| Cash and equivalents (year end) | $7.1M | $3.2M | $4.5M | $11.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Champions Oncology, Inc.
- Ticker
- CSBR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Baltimore, MD
- Incorporated in
- DE
- Fiscal year end
- April 30
- SEC CIK
- 771856
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
Frequently asked questions
What exchange is Champions Oncology, Inc. listed on?
Champions Oncology, Inc. trades on the Nasdaq under the ticker symbol CSBR.
What industry is Champions Oncology, Inc. in?
Champions Oncology, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Champions Oncology, Inc. headquartered?
Champions Oncology, Inc.'s business address on file with the SEC is in Baltimore, MD.
When does Champions Oncology, Inc.'s fiscal year end?
Champions Oncology, Inc.'s fiscal year ends on April 30.
How much revenue did Champions Oncology, Inc. report?
Champions Oncology, Inc. reported $59.4M in revenue for calendar year 2025, according to its SEC filings.